mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.9 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |